CrushSCI.com
90.4平均天数
83中位天数
26最短天数
178最长天数
232025发文量

Paper Review Records

全部论文审稿周期

15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

144 天

Bioactivation and reactivity research advances – 2025 year in review

作者
Joyce Liu; Upendra A. Argikar; Pietro Brunetti; Maria Chatzopoulou; Sungjoon Cho; Alf Claesson; Deepika Dhaware; Jakob Lang; Bin Ma; Shuguang Ma; Hlaing Maw; Grover P. Miller; Simone Schadt; Herana Kamal Seneviratne; Lloyd Wei Tat Tang; Caroline Wei; S. Cyrus Khojasteh展开收起
作者单位
1. Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc; 2. Non-clinical Development, Gates Medical Research Institute; 3. Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd; 4. UCB; 5. Awametox AB; 6. DMPK and Safety Sciences, Orion Pharma; 7. Department of Drug Metabolism and Pharmacokinetics, Gilead Sciences, Inc; 8. Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc; 9. Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences; 10. Department of Chemistry and Biochemistry, University of Maryland, Baltimore County; 11. Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc; 12. Quantitative Clinical Pharmacology, Daiichi Sankyo Inc展开收起
PDF源文件 DOI 网页
43 天

Drug transporters in drug disposition – highlights from the year 2025

作者
Philip Sandoval; Pallabi Mitra; Masanori Nakakariya; Diane Ramsden; Charles J. Rotter; Ning Ding; Paresh P. Chothe展开收起
作者单位
1. Takeda Development Center Americas, Inc. (TDCA); 2. Department of Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals Inc.; 3. Takeda Pharmaceutical Company Limited; 4. Preclinical Development, Korro Bio, Inc.; 5. Rapport Therapeutics; 6. Drug Metabolism and Pharmacokinetics, Oncology Research and Development, AstraZeneca展开收起
PDF源文件 DOI 网页
178 天

Herbal supplements and anti-tuberculosis therapy: unlocking hidden interactions for better multidrug-resistant tuberculosis management

作者
Siva Bhukya; Ravi Adinarayan Somabattini; Neelanjan Chowdhury; Sathi Sarkar; Anish Kumar Das; Kabita Mahato; Hanumu Korra; Satheesh Kumar Nanjappan展开收起
作者单位
1. Department of Natural Products, National Institute of Pharmaceutical Education and Research (NIPER) Kolkata展开收起
PDF源文件 DOI 网页
57 天

Biotransformation research advances—2025 year in review

作者
Lionel Cheruzel; Upendra A. Argikar; Pietro Brunetti; Maria Chatzopoulou; Luying Chen; Sungjoon Cho; Deepika Dhaware; Carley J. S. Heck; Chandrashekhar Honrao; S. Cyrus Khojasteh; Jed N. Lampe; Jakob Lang; Bin Ma; Shuguang Ma; Karoline Rehm; Jessica A. Rowley; Herana Kamal Seneviratne; Hyeonglim Seo; Lloyd Wei Tat Tang; Yue-Ting Wang; Caroline Wei展开收起
作者单位
1. Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc.; 2. Non-clinical Development, Gates Medical Research Institute; 3. Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd; 4. UCB; 5. Department of Pharmaceutical Sciences, China Innovation Center of Roche; 6. DMPK and Safety Sciences, Orion Pharma; 7. Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc.; 8. Pharmacokinetics, Dynamics, Metabolism, and Bioanalytics, Merck & Co., Inc.; 9. Department of Pharmaceutical Sciences, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; 10. Department of Drug Metabolism and Pharmacokinetics, Gilead Sciences, Inc.; 11. Department of Chemistry and Biochemistry, University of Maryland; 12. Quantitative, Translational & ADME Sciences (QTAS), AbbVie; 13. Quantitative Clinical Pharmacology, Daiichi Sankyo Inc.展开收起
PDF源文件 DOI 网页
87 天

Pharmacomicrobiomics in precision pharmacotherapy: bidirectional microbial-drug interactions as a key determinant of therapeutic response

作者
Serap Yalçın Azarkan; Habibe Sema Arslan Ünal; Sevinç Akçay展开收起
作者单位
1. Department of Medical Pharmacology, Faculty of Medicine, Kırşehir Ahi Evran University; 2. Department of Medical Genetics, Faculty of Medicine, Kırşehir Ahi Evran University; 3. Department of Molecular Biology and Genetics, Faculty of Science and Art, Kırşehir Ahi Evran University展开收起
PDF源文件 DOI 网页
140 天

Population pharmacokinetics of levofloxacin: a systematic review

作者
Yifan Ding; Xianghai Zeng; Jing Zou; Yuxue Zhou; Jiali Zhang; Zhao Chang; Shengnan Zhang; Meng Lv展开收起
作者单位
1. Department of Pharmacy, Children’s Hospital Affiliated to Zhengzhou University展开收起
PDF源文件 DOI 网页

FAQ

DRUG METABOLISM REVIEWS审稿要多久?

截至2026-11-19,CrushSCI 收录了 DRUG METABOLISM REVIEWS 的 15 篇完整审稿记录。最快一篇从收稿到录用用了 26 天(Cytochrome P450-derived arachidonic acid metabolites as emerging therapeutic targets in menopause-associated cardiac hypertrophy,2026-04-01 收稿,2026-04-27 录用),最慢一篇用了 178 天;平均 90.4 天,中位数 83 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。